A Nougou1, M Suter. 1. Department of Surgery, Hôpital du Chablais, Aigle-Monthey, Switzerland.
Abstract
BACKGROUND: Morbidly obese patients are at high risk to develop gallstones, and rapid weight loss after bariatric surgery further enhances this risk. The concept of prophylactic cholecystectomy during gastric bypass has been challenged recently because the risk may be lower than reported earlier and because cholecystectomy during laparoscopic gastric bypass may be more difficult and risky. METHODS: A review of prospectively collected data on 772 patients who underwent laparoscopic primary gastric bypass between January 2000 and August 2007 was performed. The charts of patients operated before 2004 were retrospectively reviewed regarding preoperative echography and histopathological findings. RESULTS: Fifty-eight (7.5%) patients had had previous cholecystectomy. In the remaining patients, echography showed gallstones or sludge in 81 (11.3%). Cholecystectomy was performed at the time of gastric bypass in 665 patients (91.7%). Gallstones were found intraoperatively in 25 patients (3.9%), for a total prevalence of gallstones of 21.2%. The age of patients with gallstones was higher than that of gallstone-free patients (43.5 vs 38.7 years, p<0.0001). Of the removed specimens, 81.8% showed abnormal histologic findings, mainly chronic cholecystitis and cholesterolosis. Cholecystectomy was associated with no procedure-related complication, prolonged duration of surgery by a mean of 19 min (4-45), and had no effect on the duration of hospital stay. Cholecystectomy was deemed too risky in 59 patients (8.3%) who were prescribed a 6-month course of ursodeoxycolic acid. CONCLUSION: Concomitant cholecystectomy can be performed safely in most patients during laparoscopic gastric bypass and does not prolong hospital stay. As such, it is an acceptable form of prophylaxis against stones forming during rapid weight loss. Whether it is superior to chemical prophylaxis remains to be demonstrated in a large prospective randomized study.
BACKGROUND: Morbidly obesepatients are at high risk to develop gallstones, and rapid weight loss after bariatric surgery further enhances this risk. The concept of prophylactic cholecystectomy during gastric bypass has been challenged recently because the risk may be lower than reported earlier and because cholecystectomy during laparoscopic gastric bypass may be more difficult and risky. METHODS: A review of prospectively collected data on 772 patients who underwent laparoscopic primary gastric bypass between January 2000 and August 2007 was performed. The charts of patients operated before 2004 were retrospectively reviewed regarding preoperative echography and histopathological findings. RESULTS: Fifty-eight (7.5%) patients had had previous cholecystectomy. In the remaining patients, echography showed gallstones or sludge in 81 (11.3%). Cholecystectomy was performed at the time of gastric bypass in 665 patients (91.7%). Gallstones were found intraoperatively in 25 patients (3.9%), for a total prevalence of gallstones of 21.2%. The age of patients with gallstones was higher than that of gallstone-freepatients (43.5 vs 38.7 years, p<0.0001). Of the removed specimens, 81.8% showed abnormal histologic findings, mainly chronic cholecystitis and cholesterolosis. Cholecystectomy was associated with no procedure-related complication, prolonged duration of surgery by a mean of 19 min (4-45), and had no effect on the duration of hospital stay. Cholecystectomy was deemed too risky in 59 patients (8.3%) who were prescribed a 6-month course of ursodeoxycolic acid. CONCLUSION: Concomitant cholecystectomy can be performed safely in most patients during laparoscopic gastric bypass and does not prolong hospital stay. As such, it is an acceptable form of prophylaxis against stones forming during rapid weight loss. Whether it is superior to chemical prophylaxis remains to be demonstrated in a large prospective randomized study.
Authors: L James Wudel; J Kelly Wright; Jacob P Debelak; Tara M Allos; Yu Shyr; William C Chapman Journal: J Surg Res Date: 2002-01 Impact factor: 2.192
Authors: R O Kamrath; L J Plummer; C N Sadur; M A Adler; W J Strader; R L Young; R L Weinstein Journal: Am J Clin Nutr Date: 1992-07 Impact factor: 7.045
Authors: S Papavramidis; N Deligianidis; T Papavramidis; K Sapalidis; M Katsamakas; O Gamvros Journal: Surg Endosc Date: 2003-04-28 Impact factor: 4.584
Authors: Leonardo Villegas; Benjamin Schneider; David Provost; Craig Chang; Daniel Scott; Thomas Sims; Lois Hill; Linda Hynan; Daniel Jones Journal: Obes Surg Date: 2004-02 Impact factor: 4.129
Authors: Chad G Ball; Andrew W Kirkpatrick; David R Williams; Jeffrey A Jones; J D Polk; James M Vanderploeg; Mark A Talamini; Mark R Campbell; Timothy J Broderick Journal: Can J Surg Date: 2012-04 Impact factor: 2.089
Authors: Robert B Dorman; Wei Zhong; Anasooya A Abraham; Sayeed Ikramuddin; Waddah B Al-Refaie; Daniel B Leslie; Elizabeth B Habermann Journal: Obes Surg Date: 2013-11 Impact factor: 4.129